Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Listening...

Search Results

No Results

    Sorry, I don't understand. Please try again

    1. Home/
    2. News/
    3. Health & wellness/
    4. Made in the shade: A new study looks at why a beach umbrella and high SPF sunscreen could be a good combo
    JAMA Sunscreen Image

    Made in the shade: A new study looks at why a beach umbrella and high SPF sunscreen could be a good combo

    Have these dark and dreary winter days inspired you to plan a trip to the Caribbean? Before you make a beeline for that beach umbrella, don’t forget to apply some high SPF sunscreen.

    According to a Johnson & Johnson study recently published in JAMA Dermatology, researchers found that sitting in the shade alone doesn’t adequately protect your skin from the sun’s harmful UV rays. Study participants who spent 3.5 hours on a sunny beach were divided into two groups: One sat under a beach umbrella with no other sun protection; the other applied SPF 100+ sunscreen, without any umbrella coverage.

    Afterwards, 78% of people in the umbrella group showed signs of sunburn versus just 25% in the sunscreen group, suggesting that the sunscreen offered significantly better protection.

    “Umbrella shade alone may not provide sufficient protection for extended sun exposure,” says the study’s lead author Hao Ou-Yang, Ph.D., Manager, Medical Research, R&D Fellow, Johnson & Johnson. “Although using SPF 100 was better than simply sitting in the shade, neither prevents sunburn completely. That’s why it’s essential to use a combination of sun protection methods.”

    So when you get to the beach (or sit outside anywhere on a bright day), opt for multiple forms of protection—such as sunscreen, shade and hats—and then crack open a novel and order that fruity drink.

    More from Johnson & Johnson

    Striving for a cure for multiple myeloma: What HCPs need to know

    Jordan Schecter, M.D., leader of Johnson & Johnson’s end-to-end development strategy for multiple myeloma, shares insight on the evolving treatment landscape of this rare blood cancer.

    The future of immunology

    Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.

    What is inflammation?

    Inflammation is the body’s natural response to injury or infection. But when it lingers, inflammation can lead to immune-mediated inflammatory diseases. Learn how Johnson & Johnson is innovating to help bring relief to those living with chronic inflammatory conditions.